MEET YOUR NEW AI CLINICAL ASSISTANT /// GET EARLY ACCESS
We empower clinicians through our platform to optimize medication selection/dose and track their patient’s response to treatment. Our pharmacogenomic test results along with patient reported outcome (PRO) software help facilitate a more personalized approach to treatment.
Contact UsMany factors influence a patient’s treatment and response to medications. Pharmacogenomics (PGx) is an objective component to provide personalized treatment and improve clinical outcomes.
The Tempus nP pharmacogenomic test can help inform medication selection and dose for patients who are experiencing depression, anxiety, ADHD, and other mental health conditions.
Patients who receive PGx testing with Tempus also have access to Tempus PRO™, a digital tool that allows you to track your patient’s response between appointments. You can now easily and accurately measure patient treatment response over time, to deliver better mental health care.1
1. Preliminary Results of Symptom Tracking using Tempus PRO™ of Patients with PGx Testing From a Real-World Clinical Dataset Poster. Psych Congress 2022 September 17-20, 2022 New Orleans.
Determining the appropriate medication for your patient at the right dose is just the first step in mental health treatment. Now you can easily and accurately measure your patient’s response to your selected treatment with Tempus PRO™, which is a part of the Tempus Mental Health Platform.
Learn more
Sample collection kits can be sent directly to patients and Tempus can guide your patients through the sample collection process. Our pharmacogenomic test can help optimize medication and dose selection, while Tempus PRO™ can help monitor your patient’s response to treatment remotely.
All Tempus tests must be ordered by a healthcare provider. Collection kits to obtain a buccal swab sample can be sent to your clinic or can be shipped directly to your patients. Our kits include easy-to-follow instructions and packaging for convenient and fast shipping to our lab.
Order Tempus
Sample collection & Tempus PRO™ activation
View your patient’s results
In addition to helping patients today, Tempus is building the world’s largest dataset of matched clinical and molecular de-identified psychiatric patient records. Tempus is providing access through the Tempus+ program to participating institutions to accelerate advancements in clinical care to help advance personalized psychiatric patient care for tomorrow.
The Tempus Platform can be integrated with your EHR to enable you to remain focused on patient care.
Learn morePharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials
Read publicationSymptom Tracking Using Tempus PRO™ in Patients With Pharmacogenetic Testing From A Real-World Dataset
Read publicationPrevalence of Pharmacogenomic Actionability in >11,000 Patients Receiving Psychiatric Care
Read publicationA hypothetical case study on how insights from the Tempus nP pharmacogenomics report can inform treatment decisions in clinical practice.
Read case studyThis real-world data set shows the impact of using Tempus PRO™ to digitally measure patient treatment response.
Read case studyIn this on-demand webinar, Dr. Brian Forsythe shares how he incorporates PGx testing into clinical practice to inform treatment decisions for patients.
Watch replayTo ensure transparency, Tempus performs a benefits check and contacts your patient if we expect your patient’s out-of-pocket cost to exceed $295. We believe cost should never prevent patients from receiving the medical care they need, and we want patients to feel comfortable knowing what they will owe. As a result, Tempus offers several different payment options that patients can choose from depending on their insurance status.
Tempus also offers a financial assistance program to provide access to our tests for patients in financial need. If you have any questions, please call or text our Customer Success Team at 312-598-9961.
This is the future of healthcare.